Granted Patent
Utility
US 6,676,966
· Confirmation No. 3752
EXTENDED RELEASE METFORMIN HYDROCHLORIDE FORMULATIONS
Patented Case
View Patent ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2003-11-21 | IFEE |
Issue Fee Payment (PTO-85B) | 3 | View | |
| 2001-05-01 | TRNA |
Transmittal of New Application | 4 | View | |
| 2001-05-01 | ADS |
Application Data Sheet | 1 | View | |
| 2001-05-01 | SPEC |
Specification | 8 | View | |
| 2001-05-01 | CLM |
Claims | 4 | View | |
| 2001-05-01 | ABST |
Abstract | 1 | View | |
| 2001-05-01 | OATH |
Oath or Declaration filed | 3 | View |
Inventors
Amina Odidi
Toronto, CANADA
Isa Odidi
Toronto, CANADA
Attorneys & Agents of Record
Classification
USPC
424/464
A61K31/155
A61K9/2846
A61K9/5026
Prosecution
- Examiner
- QAZI, SABIHA NAIM
- Art Unit
- 1616
- Docket No.
- 9577-26 LAB
- Confirmation No.
- 3752
Patent Term Adjustment
-55days
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA,
VALEANT SP. Z.O.O.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA,
VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.,
VALEANT SP. Z O. O.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2019-07-03
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
CHANGE IN NAME AND COUNTRY OF INCORPORATION
Recorded 2012-08-09
CHANGE OF NAME
Recorded 2011-06-07
PATENT SECURITY RELEASE AGREEMENT
Recorded 2011-03-14
RELEASE OF SECURITY AGREEMENT
Recorded 2010-10-06
SECURITY AGREEMENT
Recorded 2010-10-04
PATENT AND TRADEMARK SECURITY AGREEMENT
Recorded 2009-06-11
from
BIOVAIL CORPORATION
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2007-12-12
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2005-01-14
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2004-12-13
from
3489469 CANADA INC.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2003-10-02
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2003-10-02
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2003-02-11
from
3489469 CANADA INC.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2003-02-11
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,676,966
- App. No.
- 09/845,496
- Filed
- 2001-05-01
- Granted
- 2004-01-13
- Examiner
- QAZI, SABIHA NAIM
- Art Unit
- 1616
- PTA
- -55 days
External Links